Getting Started with Omnipod Discover Reports

By the end of this video, you will be able to confidently navigate the Omnipod Discover report, locate relevant patient data and historical trends, interpret key metrics and effectively communicate trends and treatment optimization with your patients.

With Omnipod Discover reports, you get a detailed view of how your patient is doing and where they may need additional support. You can view, print, or download a patient's report in Omnipod Discover by selecting the patient, choosing the report duration, and then selecting view, print, or download. Download will save a pdf copy onto your local computer that will have a unique name to help you identify whose report it is with just a glance. View and print will open the report in a new browser tab.

The report consists of a Summary, Daily view, and Settings.

Start with the Summary page. This one-stop-shop provides a high-level overview of your patient’s data for the selected reporting period, including glucose and insulin patterns, trends, and key adjustable settings. It’s designed to support clinical assessment, helping you determine how well your patient is managing their diabetes and whether therapy adjustments may be needed.

While the Summary page provides high-level patterns and trends, the Daily Report can help illuminate potential underlying causes of a pattern. This section allows you to evaluate your patient’s daily experiences with Omnipod 5. It helps you pinpoint what’s working well and identify specific days or patterns that may indicate opportunities to fine-tune settings or support behavior change. This level of detail is essential for understanding variability and tailoring interventions more precisely.

Refer to the Settings page for a complete configuration snapshot. While the Summary page highlights key adjustable settings, the Settings page offers a full list of all current Omnipod 5 settings. This page could be used to help patients transfer settings to a new Omnipod 5 controller or app.  

Let’s dive deeper into the Summary page and what it offers. At the top, you’ll be able to assess device use and glycemic metrics. Time in Ranges highlights how much time a person’s glucose is below range, in range, and above range. The goals for each match the recommendations from the International Consensus Statement on Time in Range. You will also find other key glucose metrics like average glucose, glucose variability, glucose management indicator, and standard deviation. The Device Use Metrics section helps you assess how consistently your patient is using Omnipod 5 and their sensor. Key metrics include pod wear time, sensor connectivity, and time spent in automated mode vs manual mode. This can help determine if the current prescription aligns with actual use, whether a three-day pod change is appropriate or if a two-day pod change is needed, as well as how often the system is connected to a sensor and in automated mode. The goal is to be in automated mode more than 90% of the time.
The next section of the Summary includes a standardized Ambulatory Glucose Profile, or AGP, which helps you identify glucose patterns over time. The lighter shaded area represents 90% of glucose values, the darker area shows 50%, and the dark line indicates the median. The goal is for the AGP to be flat, narrow, and within target range—signaling stable glucose control. Areas with dark shading reflect where glucose values most frequently fall, while wider, lighter areas suggest greater variability that may warrant further review.

Directly beneath the AGP, you'll find bolusing behavior broken out by time of day—nighttime, morning, afternoon, and evening.  Just below this, you will see the Omnipod 5 adjustable settings. Combining this information with the AGP by time of day can help make connections between glucose patterns, bolus behavior, and system settings to better understand possible therapy adjustments and optimize outcomes. Is it the user behavior or settings that need attention?

At the bottom of the Summary report, you'll find the Insulin Summary, which breaks down how insulin is being delivered— average basal versus bolus percentage. The basal percentage is the amount of insulin delivered by the system in automated mode versus user-initiated boluses, including meal, correction, and manual doses. This section helps you evaluate average daily bolus use, bolus-to-total insulin ratio, and whether bolus dosing appears appropriate or may need adjustment. The override percentage offers insight into whether the patient feels the system’s recommendations are too aggressive or too conservative. Overall, this summary provides valuable context for understanding both insulin delivery and patient engagement with the system.

The Daily view provides a more detailed look at how your patient is interacting with their Omnipod 5 system. Each page displays three days of data to help identify patterns and insights beyond what’s shown in the Summary report. The selected report duration determines the number of days displayed in the daily report. A legend at the top of each page helps you interpret icons and graphs.

Each day in the Daily View presents a complete picture of your patient’s experience, including glucose data, bolus events, carbohydrate entries, and insulin delivery. Boluses align with the sensor glucose values, helping to correlate insulin delivery with glucose response. Loss of connection between sensor and pod, potential line of sight issues, or no active sensor will display as a gap in the sensor trend line. An arrow above the carbohydrate entry shows when patients override system recommendations, offering insight into their engagement and confidence in the system. Carbohydrate amounts are shown for meal boluses. At the bottom of each day, you will see information about automated insulin delivery illustrating how Omnipod 5 adjusts insulin every five minutes to maintain glucose control. Below this, you can see if the system is in Automated Mode, Activity Mode, Automated Limited, or Manual Mode. You can also see when the system is in Max Delivery, Insulin Paused, or Temp Basal. While this view is not intended to provide guidance for manual mode basal adjustments or reveal adaptive baseline rates, it offers context for evaluating therapy effectiveness and patient interaction.